Cardiovascular Systems, Inc. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was USD 59.14 million compared to USD 64.17 million a year ago. Net loss was USD 8.97 million compared to USD 0.056 million a year ago. Basic loss per share from continuing operations was USD 0.23. Diluted loss per share from continuing operations was USD 0.23.
For the six months, sales was USD 117.51 million compared to USD 124.71 million a year ago. Net loss was USD 17.59 million compared to USD 2.13 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.45 compared to USD 0.06 a year ago.